Rheumatoid arthritis

The value of ultrasound-defined tenosynovitis and synovitis in the prediction of persistent arthritis

Rheumatology (Oxford)Published Prospective inception cohort study

An erratum to this article was published (Rheumatology (Oxford), 1 Mar 2023 ↗)

Main finding · US-detected digit flexor tenosynovitis as predictor of persistence (independent of US joint synovitis and RF)Result — go to the resultOdds ratio 6.6 95% CI 2.0–22.1

Authors' conclusion

US-defined tenosynovitis provided independent predictive data for the development of persistent arthritis.

Study context

Population
DMARD-naïve patients with clinically apparent synovitis of one or more joints and symptom duration ≤3 months (early arthritis)
Participants
150 patients
Exposure
US-defined tenosynovitis vs US-defined synovitis and clinical and serological variables as predictors of persistent arthritis
  • Persistent arthritisn = 99
  • Resolving diseasen = 51reference
Outcome
Persistent vs resolving arthritis
Follow-up
18 months
Methodological detailsmultivariate logistic regression
  • Multivariate logistic regression

Main finding

As reported in the abstract

US-detected digit flexor tenosynovitis as predictor of persistence (independent of US joint synovitis and RF)

Odds ratio

6.6

95% CI 2.0–22.1

P = 0.002

Events by group

US-defined tenosynovitisvs US-defined synovitis and clinical and serological variables as predictors of persistent arthritis
OR 6.6 (95% CI 2.0–22.1); P = 0.002

Observational data: associations, not effects.

Further findings

US-defined digit flexor tenosynovitis as predictor in RF/ACPA-negative subcohort (adjusted for US joint synovitis)

OR (95% CI)P value
US-defined digit flexor tenosynovitis4.7 (1.4–15.8)P = 0.012

Original publication

The value of ultrasound-defined tenosynovitis and synovitis in the prediction of persistent arthritis. Rheumatology (Oxford). Published 12 April 2022. doi:10.1093/rheumatology/keac199

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.